• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

SOL Global Investments CEO Issues Statement on Sale of Latin American Assets

Share:

December 10, 2018

SOL Global Investments Corp. today makes a statement on the September 27, 2018 sale of its Latin American operations, LATAM Holdings Inc., to Aphria Inc. Brady Cobb, SOL Global’s Chief Executive Officer, releases the following statement: “SOL Global completed the sale of its Latin American assets to Aphria Inc. on September 27, 2018. These assets included valuable licenses and strategic partnerships with governments and regulators in each of the Colombian, Argentinian, and Jamaican markets. The sale also included a right of first offer and refusal in respect of an asset in Brazil. These emerging market licenses represent some of the most significant growth opportunities in the global cannabis and CBD marketplaces.

SOL Global reiterates that it is satisfied with the outcome of the transaction. The transaction – as with all transactions of this size – was thoroughly reviewed by both parties, each of which employed qualified and reputable financial analysts and prominent law firms to review the terms of the deal and received a formal valuation and majority of the minority shareholder approval as required by applicable Canadian securities laws. The transaction also received approval by the TSX and the CSE.

Sol Global – and numerous other prominent cannabis companies – have recognized that the cannabis market in Latin America has not yet realized its massive potential. Favorable climate conditions in many Latin American countries, along with continued liberalization of government regulation and the comparatively lower cost of production and cultivation, will make Latin American countries a major participant in the emerging global cannabis economy over the next decade and beyond.

Quintessential Capital Management and Hindenburg Research are financially invested in destroying the stock prices of SOL Global and other cannabis companies by publicizing false and/or purposely misleading information to apply negative pressure to stock prices. Our company will not engage in a back-and-forth with these bad-faith actors at this time. Further, we will be empaneling a special committee of our Board as well as engaging independent counsel to review the false allegations levied against SOL Global by these bad actors and to pursue all available legal relief against parties that have manipulated SOL Global’s stock price via false and/or misleading information.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

We welcome our current investors and potential new investors to look closely at our capital investments and financial statements and performance before they invest with us, and would expect nothing less.”

Date: December 10, 2018

Source: MarketWatch

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Amazon buys PillPack, an online pharmacy, for just under $1BAmazon buys PillPack, an online pharmacy, for just under $1B
  • Revelstoke’s Carrus Acquires Archetype InnovationsRevelstoke’s Carrus Acquires Archetype Innovations
  • Nuclei Scores $33M for AI-Enabled Pathology Platform and More Digital Health FundingsNuclei Scores $33M for AI-Enabled Pathology Platform and More Digital Health Fundings
  • Walgreens to Invest $1B in VillageMD to Open 500 to 700 Full-Service Doctor OfficesWalgreens to Invest $1B in VillageMD to Open 500 to 700 Full-Service Doctor Offices
  • Stepping Stones Group Acquires New England ABAStepping Stones Group Acquires New England ABA
  • Todos Medical Enters Into Binding Agreement to Acquire all 3CL Protease Biology-Related Assets and Intellectual Property from NLC PharmaTodos Medical Enters Into Binding Agreement to Acquire all 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
  • Theme Parks Have a Lot to Teach Healthcare Systems About Patient ExperienceTheme Parks Have a Lot to Teach Healthcare Systems About Patient Experience
  • The Valley of Life: A national life science strategy, and the promise of springThe Valley of Life: A national life science strategy, and the promise of spring

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications